Episode 123: My MS Toolkit with Dr. Anna Kratz

Episode 123: My MS Toolkit with Dr. Anna Kratz

Publication date: Jan 06, 2020

Access to MS symptom self-management care is extremely limited. That’s why my guest, Dr. Anna Kratz, and her colleagues created My MS Toolkit — a web-based, self-guided symptom self-care program designed especially for people with MS. (And it’s FREE!) We’re talking with Dr. Kratz about how My MS Toolkit was developed and what makes it such a powerful online tool for people living with MS. We’re also talking about the latest petitions filed with the Supreme Court in the battle over the Affordable Care Act (and why this is so vitally important to people affected by MS!). If you’re using gabapentin (Neurontin) to manage MS pain, we’ll tell you about the warning that was just issued by the FDA. Yet another study gives us yet another reason to start disease-modifying therapy as soon as possible. And we’ll explain why collecting real-world data about MS is so important, and what a team of MS experts is recommending to improve the process of real-world data collection and analysis. We have a lot to talk about! Are you ready for RealTalk MS??! ___________ Where I’ll Be in January :27 National MS Society Joins 23 Other Patient Organizations in Requesting Supreme Court Expedites Its Review of the ACA 3:00 FDA Issues Warning About Gabapentinoids 6:51 Disease-Modifying Therapy Use Has Changed the ‘Natural History’ of Relapsing-Remitting MS 7:57 Paper Explores How Real-World Data Can Be Better Leveraged to Speed Solutions to People Living with MS 9:34 My Interview with Dr. Anna Kratz 15:04 Share This Episode 36:00 Download the RealTalk MS App 36:29 ___________ SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: http://realtalkms.com/123 ___________ ADD YOUR VOICE TO THE CONVERSATION I’ve always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.comPhone: (310) 526-2283 ___________ LINKS If your podcast app doesn’t allow you to click on these links, you’ll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com My MS Toolkit FDA Warns About Serious Breathing Problems when Gabapentin and Pregabalin Are Used With CNS Depressants or By Patients with Lung Problems STUDY: Outcomes in a Modern Cohort of Treated Multiple Sclerosis Patients Followed from Diagnosis Up to 15 Years Leveraging Real-World Data to Investigate Multiple Sclerosis Disease Behavior, Prognosis, and Treatment Download the RealTalk MS App for iOS Download the RealTalk MS App for Android Give RealTalk MS a Rating & Review ___________ Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 123 Hosted By: Jon Strum Guests: Dr. Anna Kratz Tags: MS, MultipleSclerosis, MSResearch, MSActivist, MSSociety, Gabapentinoids, ACA, RealTalkMS Privacy Policy

Concepts Keywords
Air Health insurance
Alexa Free Web
Allegheny Online tool
Amazon Echo Imaging
Android Important tool
Apple Web browser
Apple App Store Insurance
Area Code Telephone intervention
Behavior Change Telephone therapy
Biomarkers Self care tool
Blood Energy management
CARE Social network
Central Nervous System Psychotherapy
Chronic Illness English-language films
Clinical Trial Draft:Melissa Chase
Clinical Trials Neuroscience
Cocktail CBT
Coffee Smartphone
Cognitive Behavioral Therapy Android
Cohort Study
Columbia House
CVT
Depressants
Depression Mood
Diabetes
Disability
Echo Dot
Energy Management
Epidemiologists
European Medicines Agency
Fatigue
FDA
Fibromyalgia
Fox
Gabapentin
Gabba
Google Play Store
Hotline
HP
Individual Mandate
Insurance
IOS
Lung
Lyrica
Mastering
Metadata
Miami
Michigan
MS 7
Multiple Sclerosis
Nas
Neurologist
Neurontin
Noise
North America
Observational Studies
Packet
Pain
Patient Reported Outcomes
Pennsylvania
Physical Activity
Physical Rehabilitation
Podcast
Pregabalin
Prognosis
Psychologist
Representative
Seattle
Sleep
Smartphone
Social Network
Stakeholder
Stress
Supreme Court
Symptom
Tablets
Team Michigan
Telephone
Texas
Twitter
University
Washington
Wearable Sensors

Semantics

Type Source Name
drug DRUGBANK Gabapentin
drug DRUGBANK Trihexyphenidyl
drug DRUGBANK Tropicamide
drug DRUGBANK Coenzyme M
drug DRUGBANK Pregabalin
disease MESH Multiple Sclerosis
disease MESH Diagnosis
drug DRUGBANK Methyltestosterone
disease MESH Privacy

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *